Edition:
United Kingdom

Accuray Inc (ARAY.OQ)

ARAY.OQ on NASDAQ Stock Exchange Global Select Market

5.30USD
19 Jan 2018
Change (% chg)

-- (--)
Prev Close
$5.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
181,927
52-wk High
$6.00
52-wk Low
$3.60

Chart for

About

Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife... (more)

Overall

Beta: 1.23
Market Cap(Mil.): $372.67
Shares Outstanding(Mil.): 83.75
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 149.38 16.58
EPS (TTM): -- -- --
ROI: -- 9.44 10.60
ROE: -- 14.87 14.19

BRIEF-Beverly Huss Joins Accuray Board Of Directors

* ACCURAY INC - WITH APPOINTMENT OF HUSS, CO'S BOARD CONSISTS OF SEVEN MEMBERS Source text for Eikon: Further company coverage:

11 Jan 2018

BRIEF-Accuray Elects Net Share Settlement For 3.50 Pct Series A Convertible Senior Notes

* ACCURAY ELECTS NET SHARE SETTLEMENT FOR 3.50% SERIES A CONVERTIBLE SENIOR NOTES DUE 2018

03 Jan 2018

BRIEF-Accuray Inc reports Q1 loss per share $0.11

* Accuray generated $55.6 million in first quarter gross orders; revenue increased 5 percent year over year

24 Oct 2017

Exclusive: Siemens mandates three banks for IPO of Healthineers unit - sources

FRANKFURT Germany's Siemens AG has mandated Goldman Sachs , Deutsche Bank and JP Morgan as lead organizers of an initial public offering (IPO) of its Healthineers unit, sources familiar with the matter said.

24 Oct 2017

EXCLUSIVE-Siemens mandates three banks for IPO of Healthineers unit -sources

* Stock market float expected in June/July 2018 -sources (Adds valuation, details)

24 Oct 2017

BRIEF-European Court Of Appeal rejects Varian's attempt to reverse customer purchase of Accuray TomoTherapy system

* European Court Of Appeal rejects Varian's attempt to reverse customer purchase of Accuray TomoTherapy system

19 Oct 2017

BRIEF-Accuray reports Q4 loss per share of $0.06

* Accuray reports fourth quarter and fiscal 2017 financial results

22 Aug 2017

BRIEF-Accuray issues $85 mln principal amount of 3.75 pct convertible senior notes

* Accuray Inc says ‍on August 7, issued $85 million aggregate principal amount of its 3.75% convertible senior notes due 2022 - sec filing​ Source text: (http://bit.ly/2umHI40) Further company coverage:

08 Aug 2017

BRIEF-Accuray says receives 510(k) clearance for IDMS data management system upgrade for Tomotherapy system

* Says receives 510(k) clearance for IDMS data management system upgrade for Tomotherapy system Source text for Eikon: Further company coverage:

31 Jul 2017

BRIEF-Accuray enhances capital structure through convertible debt transactions

* Accuray Inc - company has also entered into agreements to privately sell $32 million aggregate principal amount of new notes for cash to certain other investors

28 Jul 2017

Competitors

Earnings vs. Estimates